Shaping the future of medical imaging with AI.
At Gleamer, we are dedicated to pioneering the future of medical imaging by building a comprehensive AI copilot which will pave the way for precision medicine. Our commitment lies in making optimal care a reality for all.
Gleamer founded
Founded in Paris to bring clinically validated AI into radiology workflows, helping doctors read faster and with greater confidence.
Seed round
Raised a €1.5M seed round (incl. XAnge, Elaia, Bpifrance) to accelerate R&D and early go-to-market.
AI Factory creation
Built our internal AI Factory to industrialize data curation, training, validation and deployment of medical imaging models at scale.
BoneView launch
BoneView obtained Class IIa CE marking and began rolling out AI fracture detection to hospitals and radiology groups.
Series A
Closed a €7.5M Series A to scale BoneView’s international rollout and expand the product pipeline.
First Radiology paper
First publication in Radiology demonstrating clinical impact of BoneView, supporting safer and more reliable fracture detection on X-rays.
BoneView US launch
BoneView received FDA 510(k) clearance, enabling commercial rollout in the U.S. for AI-assisted fracture detection on radiographs.
ChestView launch
Introduced ChestView, a CE-marked AI solution for chest X-ray interpretation, helping highlight key thoracic findings in routine reads.
BoneAge launch
Launched BoneAge (MDR CE-certified), automating pediatric bone age assessment from hand radiographs to save time and improve consistency.
BoneMetrics launch
Launched BoneMetrics, an MDR CE-certified solution for MSK measurements, automating key angles and lengths to support orthopedic decision-making.
Series B
Raised €27M (Series B) to expand the portfolio, strengthen teams in Europe/US, and accelerate international growth.
ChestView US and BoneMetrics US launch
ChestView and BoneMetrics received FDA 510(k) clearance, expanding Gleamer Copilot’s chest X-ray AI suite in the U.S. market.
BreastView launch
BreastView received CE certification, bringing AI support for lesion detection in 2D mammography.
LungCT, BoneCT launch
BreastView received CE certification (Feb 2025), bringing AI support for lesion detection and triage in 2D/3D mammography.
Caerus acquisition
Acquired Caerus Medical to add lumbar spine MRI AI capabilities and expand Gleamer’s multimodality portfolio.
Pixyl acquisition
Acquired Pixyl to add CE/FDA-cleared neuro MRI applications, accelerating Gleamer’s expansion into MRI.
We’re on a mission to build a better healthcare
Our story
Founded in 2017 by Christian Allouche, Alexis Ducarouge, and Dr Nor-Eddine Regnard, Gleamer is a French medtech company positioned as a leading global player in artificial intelligence applied to medical imaging. While demand for medical imaging has doubled across OECD countries over the past decade, the number of radiologists has remained relatively stable. To address this growing healthcare challenge, Gleamer has developed an innovative platform that supports radiologists in their diagnostic process through semi-automated pre-diagnosis of medical images, enabling the detection of pathologies and the generation of reliable, structured reports.
The company raised €27M in Series B, joined the French Tech 120, and accelerated its growth through the acquisitions of Pixyl (neurological MRI) and Caerus Medical (musculoskeletal MRI). Today, Gleamer delivers CE and FDA-cleared AI solutions across X-ray, CT, and MRI, with a clear mission: improving quality of care while reducing radiologists’ workload.
The company raised €27M in Series B, joined the French Tech 120, and accelerated its growth through the acquisitions of PixyToday, Gleamer continues its international expansion, steadily enriches its portfolio of CE- and FDA-cleared solutions, and accelerates its mission: to improve quality of care while reducing radiologists’ workload, through trusted clinical AI seamlessly integrated into hospital workflows. Today, Gleamer delivers CE and FDA-cleared AI solutions across X-ray, CT, and MRI, with a clear mission: improving quality of care while reducing radiologists’ workload.
120+ employees
Employees worldwide
33 years old average age
AI revolution is waiting for you